Does Transcription Factor Induced Pluripotency Accurately Mimic Embryo Derived Pluripotency?
Overview
Authors
Affiliations
When Takahashi and Yamanaka first demonstrated that just four transcription factors could reprogram a fibroblast to a pluripotent state, the first wave of data to emerge focused on how similar these induced pluripotent stem cells (iPSCs) were to embryo-derived pluripotent stem cells (ESCs) [1]. The next wave of data focused on determining the degree of difference between iPSCs and ESCs [2]. Now the focus is on tweaking the process to generate iPSCs that are more similar to ESCs [3,4]. Because transcription factor based reprogramming allows for nearly any type of cell to be created from any donor cell, there is obviously enormous interest in this technique as a tool for both basic developmental biology and for clinical applications. In this review, I will attempt to summarize the data that serve to distinguish these types of pluripotent stem cells and speculate on the ramifications of any differences.
Adelaja A Int J Health Sci (Qassim). 2017; 11(2):21-27.
PMID: 28539859 PMC: 5426416.
Kim J, Khalid O, Namazi A, Tu T, Elie O, Lee C Stem Cells. 2014; 32(6):1468-79.
PMID: 24519983 PMC: 4037450. DOI: 10.1002/stem.1675.
Zhang L, Pan Y, Qin G, Chen L, Chatterjee T, Weintraub N Cell Cycle. 2014; 13(5):762-71.
PMID: 24394703 PMC: 3979912. DOI: 10.4161/cc.27677.
Epigenetics of reprogramming to induced pluripotency.
Papp B, Plath K Cell. 2013; 152(6):1324-43.
PMID: 23498940 PMC: 3602907. DOI: 10.1016/j.cell.2013.02.043.